Quantcast

Latest Copayment Stories

2009-08-24 14:52:00

WASHINGTON, August 24 /PRNewswire/ -- As members of Congress continue to debate proposals for health care reform, the National Pharmaceutical Council (NPC) has released a new report on an important approach being used by leading edge employers for improving patient health outcomes - Value-Based Insurance Design (VBID). Featuring case studies, the report takes a closer look at how VBID is helping employers nationwide "get more health out of every health care dollar." The report,...

2009-08-11 22:00:00

MILWAUKEE, Aug. 11 /PRNewswire/ -- A recently mandated settlement in a class action suit involving drug wholesaler McKesson Corporation and data publishers First Data Bank and Medispan is impacting pharmacy benefit programs in both the short and long terms, according to Greg Rucinski, President & CEO for TRICAST, Inc., a leading next-generation health information business. "There's a whole lot more than meets the eye in what the U.S. District Court in Massachusetts mandated. Pharmacy...

2009-06-15 12:16:00

The New Pharmacy Benefit Evaluator Analyzes Health Plan Pharmacy Benefit Structure, Spending and the Plan-PBM Relationship to Inform Managed Care Sales Strategy Development NASHVILLE, Tenn., June 15 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, has enhanced its Pharmacy Benefit Evaluator, a Web-based product that analyzes health plan pharmacy benefit structure and spending and the health plan-to-pharmacy benefit manager (PBM) relationship...

2009-06-02 08:02:07

Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive. Insurance plans differ greatly in their coverage of and cost sharing for biologic DMARDs, sometimes shifting a large portion of the cost of...

2009-04-23 08:00:00

WASHINGTON, April 23 /PRNewswire-USNewswire/ -- The United States District Court for the District of Massachusetts has preliminarily approved the settlement of a class action with McKesson, a large drug wholesaler. The lawsuit, called New England Carpenters Health Benefits Fund v. First DataBank, Inc., concerns the pricing of more than 450 brand-name drugs, and consumers and Third-Party Payors ("TPPs") could get money back. Prescription drugs are often priced using certain benchmarks....

2009-04-20 07:00:00

$42 Billion Savings Opportunity Still Remains for Nation ST. LOUIS, April 20 /PRNewswire-FirstCall/ -- In the midst of the financial crisis and skyrocketing healthcare costs, greater use of generic drugs and lower-cost brand drugs led to a record-low spending trend for 2008 according to data from Express Scripts (Nasdaq: ESRX), one of the nation's largest pharmacy benefit managers. Overall pharmacy cost trend for Express Scripts clients was 3.0 percent for 2008, down 2.5 percentage...

2009-03-04 07:00:00

GLEN ROCK, N.J., March 4 /PRNewswire/ -- Fingertip Formulary, the leading provider of access to and insight into US formulary data, introduces one-click access to customized formulary data and co-pay reports. Fingertip Formulary Analytics, the leading web-based formulary reporting platform, now offers subscribers the ability to save report selections for easy future access. The analytics platform offers eleven comprehensive reports that provide real-time current and historical data on...

2009-03-03 12:42:00

BOSTON, March 3 /PRNewswire-USNewswire/ -- Important deadlines are approaching for class members of a proposed class action settlement related to the average wholesale prices of certain prescription drugs. The United States District Court for the District of Massachusetts granted preliminary approval of the Proposed Settlement in July 2008. In the lawsuit, In re: Pharmaceutical Industry Average Wholesale Price Litigation, No. 01-CV-12257-PBS, MDL No. 1456, plaintiffs claimed that drug...

2009-01-14 13:03:00

American Heart Association rapid access journal report: Study highlights: -- Cholesterol-lowering drug adherence drops with an increase in VA prescription co-payments. -- The odds of going for 90 straight days without medication was three times higher among patients in the all co-payment group and twice as high in patients in the some co-payment group when compared to the exempt group (received prescriptions without a co-payment). -- Researchers suggest charging lower co-payments for...

2008-12-09 12:49:00

ROCKVILLE, Md., Dec. 9 /PRNewswire-USNewswire/ -- Electronic prescribing (e-prescribing) systems that allow doctors to select lower cost or generic medications can save $845,000 per 100,000 patients per year and possibly more system-wide, according to findings from a new study funded by HHS' Agency for Healthcare Research and Quality. The finding may have important financial implications, the study authors concluded. As e-prescribing systems become more widely available and easier to use,...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related